The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Long-Term Follow-Up After Gene Therapy for Canavan Disease
Open accessAbstract
Gene therapy for Canavan disease results in a decrease in pathologically elevated N-acetyl-aspartate concentrations in the brain and long-term clinical stabilization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AAV vector administration to the CNS has an excellent safety and efficacy profile.”
From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [59]
Experimental — accuracy not yet measuredIn the citing paper
“The reversal of biochemical and structural biomarkers suggests that the process is reversible; however, earlier intervention is suspected to lead to a more robust clinical response.54”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robust Locally Weighted Regression and Smoothing Scatterplots
Cleveland, W. S. (1979) · Journal of the American Statistical Association · doi:10.1080/01621459.1979.10481038 · Cited by 11,594
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's Disease
Escolar, M. L., Poe, M. D., Provenzale, J. M., Richards, K. C., Allison, J., Wood, S., Wenger, D. A., Pietryga, D., Wall, D., Champagne, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042604 · Cited by 709
Kreis, R., Ernst, T., & Ross, B. D. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910300405 · Cited by 681
Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies
Simmons, M. L., Frondoza, C. G., & Coyle, J. T. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90101-s · Cited by 626
Urenjak, J., Williams, S. R., Gadian, D. G., & Noble, M. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08875.x · Cited by 503
Haley, S. M. (1998) · Medical Entomology and Zoology · Cited by 484
Cord-Blood Transplants from Unrelated Donors in Patients with Hurler's Syndrome
Staba, S. L., Escolar, M. L., Poe, M., Kim, Y., Martin, P. L., Szabolcs, P., Allison-Thacker, J., Wood, S., Wenger, D. A., Rubinstein, P., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032613 · Cited by 478
N -Acetylaspartate in neuropsychiatric disorders
Tsai, G., & Coyle, J. T. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00014-m · Cited by 422
Aspartoacylase deficiency and N‐acetylaspartic aciduria in patients with canavan disease
Matalon, R., Michals, K., Sebesta, D., Deanching, M., Gashkoff, P., Casanova, J., Optiz, J. M., & Reynolds, J. F. (1988) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320290234 · Cited by 404
Research works printed but not linked: 1
- 10.1002/ana.102 · doi:10.1002/ana.102
Cited by
Gene therapy returns to centre stage
Naldini, L. (2015) · Nature · doi:10.1038/nature15818 · Cited by 1,184
Engineering adeno-associated virus vectors for gene therapy
Li, C., & Samulski, R. J. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0205-4 · Cited by 1,175
Self-citationImmune responses to AAV vectors: overcoming barriers to successful gene therapy
Mingozzi, F., & High, K. A. (2013) · Blood · doi:10.1182/blood-2013-01-306647 · Cited by 955
“Delivery of small amounts of AAV vectors directly into the brain has been tested in a number of trials for Parkinson disease, 13,51,52,107 Canavan disease, 14,108 and late infantile neuronal ceroid lipofuscinosis.”
Adeno-associated virus as a delivery vector for gene therapy of human diseases
Wang, J.-H., Gessler, D. J., Zhan, W., Gallagher, T. L., & Gao, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01780-w · Cited by 904
Current clinical applications of in vivo gene therapy with AAVs
Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743
Metadata
- Authors
- Leone, P., Shera, D., McPhee, S. W. J., Francis, J. S., Kolodny, E. H., Bilaniuk, L. T., Wang, D.-J., Assadi, M., Goldfarb, O., Goldman, H. W., Freese, A., Young, D., During, M. J., Samulski, R. J., & Janson, C. G.
- Affiliations
- University of Medicine and Dentistry of New Jersey (US)
- Children's Hospital of Philadelphia (US)
- AskBio (United States) (US)
- NYU Langone Health (US)
- Cooper University Hospital (US)
- University of Minnesota (US)
- University of Auckland (NZ)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Leone, Paola
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2012-12-19
- Volume
- 4
- Issue
- 165
- Pages
- 165ra163-165ra163
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC3794457
- OpenAlex
- W2119934328
- Cited by
- 307
- References
- 75
- Citations by year
- 2026: 7 · 2025: 18 · 2024: 53 · 2023: 23 · 2022: 14 · 2021: 24 · 2020: 21 · 2019: 17 · 2018: 24 · 2017: 24 · 2016: 21 · 2015: 22 · 2014: 24 · 2013: 15
- FWCI
- 11.76
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- Canavan Research Foundation
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS044576, R01-NS42120, R01NS042120)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- Canavan disease, gene therapy, aspartoacylase, leukodystrophy, N-acetylaspartate, adeno-associated virus vectors, long-term safety, brain atrophy, seizure frequency, clinical outcomes
- MeSH terms
- Aspartic Acid, Brain, Child, Child, Preschool, Humans, Infant, Prospective Studies, Genetic Therapy, Canavan Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-Term Follow-Up After Gene Therapy for Canavan Disease. https://app.cochat.ai/papers/10.1126/scitranslmed.3003454
- The paper
- Leone, P., Shera, D., McPhee, S. W. J., Francis, J. S., Kolodny, E. H., Bilaniuk, L. T., Wang, D.-J., Assadi, M., Goldfarb, O., Goldman, H. W., Freese, A., Young, D., During, M. J., Samulski, R. J., & Janson, C. G. (2012). Long-Term Follow-Up After Gene Therapy for Canavan Disease. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3003454
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.